Single dose of chimeric dengue-2/Zika vaccine candidate protects mice and non-human primates against Zika virus

por Baldwin, Whitney R., Giebler, Holli A., Stovall, Janae L., Young, Ginger, Bohning, Kelly J., Dean, Hansi J., Livengood, Jill A., Huang, Claire Y.-H.
Publicado 2021

Purified Inactivated Zika Vaccine Candidates Afford Protection against Lethal Challenge in Mice

por Baldwin, Whitney R., Livengood, Jill A., Giebler, Holli A., Stovall, Janae L., Boroughs, Karen L., Sonnberg, Stephanie, Bohning, Kelly J., Dietrich, Elizabeth A., Ong, Yee Tsuey, Danh, Hoang K., Patel, Hetal K., Huang, Claire Y.-H., Dean, Hansi J.
Publicado 2018

Persistence of Immunogenicity of a Purified Inactivated Zika Virus Vaccine Candidate in Healthy Adults: 2 Years of Follow-up Compared With Natural Infection

por Acosta, Camilo J, Diaz, Clemente, Nordio, Francesco, Han, Htay-Htay, Moss, Kelley J, Bohning, Kelly, Kumar, Pradeep, Liu, Mengya, Patel, Hetal, Pacciarini, Filippo, Mwangi, Vincent, Walter, Elke, Powell, Tim D, El Sahly, Hana M, Baldwin, Whitney R, Santangelo, Joseph, Anderson, Evan J, Dubin, Gary
Publicado 2022